Navigation Links
Innovative Psoriasis Treatment PSORENT(R) Announces Healthcare Cost Savings Potential Consistent with President Obama's Announcement on Healthcare Reform
Date:6/25/2009

want you to know that we are with you, Mr. President."

About PSORENT(R)

PSORENT(R) is a new topical solution that has the proven efficacy of a prescription medication but is available as an OTC. This aesthetically advanced, quick-drying solution is highly effective, easy and pleasant to use, and has a patient satisfaction rating of nearly 90%.

About NeoStrata

NeoStrata Company, Inc., located in Princeton, NJ develops and markets a comprehensive range of clinically-proven, dermatologist developed skin care products. These advanced therapeutic and cosmetic dermatological products are available worldwide through consumer outlets, physicians' offices and spas.

More information is available at www.neostrata.com and www.psorent.com.


'/>"/>
SOURCE NeoStrata Company, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
2. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
3. Oculus Innovative Sciences to Present at 4th Annual BIO InvestorForum Conference
4. Surgeons Develop Innovative Life-Saving Treatments to Correct Massive Bleeding in Trauma Patients
5. Raydiance Collaborates With Rutgers University and Nations Largest Tissue Bank to Develop Innovative Tissue Processing Approaches
6. YMed, Inc. Successfully Completes First Clinical Cases With Innovative VascuTraK(TM) II PTA Dilatation Catheter
7. Innovative Brain Scanning for Alzheimers Screening Unveiled
8. Gates Foundation Seeks Proposals for Innovative Global Health Research
9. In Blood Vessel Stents, Innovative Materials Allow Better Control, Delivery of Gene Therapy
10. Studies of an Innovative Catheter Ablation System for Atrial Fibrillation Reveal Excellent Outcomes, Safety Profile and Fast Procedure Times
11. CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009).../PRNewswire-FirstCall/--HeskaCorporation(HSKA);("H...ecialtyproductstotheveterinaryindustry,announcedto...supplyofbloodgasproductsandaffiliatedconsumablesfo...com.com/cgi-bin/prnh/20000622/HESKALOGO ) ,, "H...ieldofadvancedpoint-of-carediagnostics,"commentedM...
(Date:11/25/2009)...wswire/--BioTrendsResearchGroup,Inc.releasedWave1o...tinamulti-phasesyndicatedmarketresearchprojecttrac...productlaunchthroughthefirstsixmonthsofavailabilit...onfrom75uniqueDermatologistsandqualitativeinformat...elara,obstaclestouse,typicalpatienttypes,productpe...
(Date:11/25/2009)....25/PRNewswire/--RegadoBiosciences,aprivatelyheldc...swithactivecontrolagents,announcedthatDavidMazzo,P...ay21stAnnualHealthCareConferenceattheNewYorkPalace...enat1:10pm(EST)onTuesday,December1andwillincludean...ddevelopmentprogram,theanticoagulantsystem,REG1.Th...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Herley Reports Fourth Quarter and Year End Results 59611 1Herley Reports Fourth Quarter and Year End Results 59611 2Herley Reports Fourth Quarter and Year End Results 59611 3Herley Reports Fourth Quarter and Year End Results 59611 4Herley Reports Fourth Quarter and Year End Results 59611 5Herley Reports Fourth Quarter and Year End Results 59611 6Herley Reports Fourth Quarter and Year End Results 59611 7Herley Reports Fourth Quarter and Year End Results 59611 8Herley Reports Fourth Quarter and Year End Results 59611 9Herley Reports Fourth Quarter and Year End Results 59611 10Herley Reports Fourth Quarter and Year End Results 59611 11Herley Reports Fourth Quarter and Year End Results 59611 12Patent challenges reduce pharmaceutical innovation and productivity researchers suggest 59608 1Patent challenges reduce pharmaceutical innovation and productivity researchers suggest 59608 2Patent challenges reduce pharmaceutical innovation and productivity researchers suggest 59608 3Scientists use math modeling to predict unknown biological mechanism of regulation 14500 1Scientists use math modeling to predict unknown biological mechanism of regulation 14500 2
...ermanent version of the glasses ...vative prism glasses can,significantly improve the...nopia, a condition that blinds half the visual fie...ch were invented by Dr. Eli Peli, a Senior,Scienti...ted in the first,community-based multi- center tri...
...utics, Inc.,announced the successful completion of...nd, VEL-0230, which the company is investigating a...her bone diseases. In,extensive preclinical studie...ory agent that also stimulates bone formation and ...ristics strongly suggest this drug,may be an impor...
Other Medicine Technology:Prism Glasses Expand the View for Patients with Hemianopia 2Prism Glasses Expand the View for Patients with Hemianopia 3Velcura Therapeutics, Inc. Reports Successful Phase 1 Clinical Trial of Novel Bone Disease Therapy 2
(Date:11/25/2009)...5/PRNewswire/-SentinelleMedicalInc.,aleadingmanufa...areandCalgaryScientificInc.,aleadingproviderofsoft...ofAegis(TM)Breast4DAdvancedVisualizationsoftware. ...ootprintWebclientbasedmedicalimagingofferinginthem...forzero-footprintaccess-requiringnosoftwaredownloa...
(Date:11/25/2009)...ewswire/--TheBayAreaAirQualityManagementDistrictis...Air Alert forThursday,November26,2009whichban...el,bothindoorsandoutdoors. ,, "Cold,stillweathe...JackBroadbent,executiveofficeroftheAirDistrict."We...neighborsandfellowcommunitymembersthisThanksgiving...
(Date:11/25/2009)...essure? This simple question has been the focus o...ated gene Modulates High Blood Pressure in Mice & ...imple question has been the focus of intense resea...first time established a link between a novel gene...ress in mice as well as humans. The studies were d...
(Date:11/25/2009)...ological symptoms, study finds , , WEDN...de effects are among the potential problems faced ...re treated with cisplatin-based chemotherapy, a ne...orwegian men treated for unilateral testicular can...w-up survey conducted from 1998 to 2002. , The ...
(Date:11/25/2009)...vaccine carried into the body on a carefully engin...ccessfully eliminate tumors in mammals, scientists...ional Medicine . , The new approach, pioneered b...sity, uses plastic disks impregnated with tumor-sp...program the mammalian immune system to attack tumo...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2
.... scientists discover an effective method of vacci...ium Yersinia pestis//, with the details of their s...ture Immunology. Egil Lien and his colleagues a...fatty sugars in the development of an effective va...
... Waters’ missionary work to spread the Gospel to f...ecades, but it left his head pounding.// Begi...t eventually forced him to return home. Medi... caused facial throbbing, until he came to the Eug...
... blame yourself, if your taste buds get tickled at...re mention! A recent investigation into the reaso...arian food has shown that such tendencies are gene...be in the pink of health. To understand such incli...
...rotein helps lower total cholesterol, low-density ...ghtly raises high-density lipid “good” cholesterol...ed in the Sept. 1, 2006 issue of The American Jour...or the prevention and treatment of high blood chol...
...ent study reveals that short sessions (a few minut... same results as moderate exercises done for hours...inesiology at McMaster University and his team con...g finding from our study was the remarkably simila...
...to - Those Canadians who live in far-flung areas r...to the city-dwellers, primarily due to an increase...idental injury, as stated by a report released by ...nt in the god-forsaken areas of rural Canada, in s...
Other Medicine News:Health News:Different Techniques Can Help Ease Chronic Pain, Return Patients’ Smile 2Health News:Different Techniques Can Help Ease Chronic Pain, Return Patients’ Smile 3Health News:Rural Canadians, Take Care Of Your Health 2
PK®TP™ System & Controls
...PK7200 Automated Microplate System, the PK CMV-PA ...icle for the detection of cytomegalovirus. Relativ...compared to EIA measures 99.8% and 99.3% respectiv...provides excellent lot-to-lot consistency and elim...
...utination technology. Its is a fully automated blo... also handles weak D as well as syphilis and cytom...plate System delivers the very latest technology a... generation has tested over 90% of the North Ameri...
ORTHO ProVue™
Medicine Products: